Amyloid-β deposition and olfactory dysfunction in an alzheimer's disease model

Journal of Alzheimer's Disease

Volumn 37, Issue 4, 2013, Pages 699-712

  Wu, Nan ^a,b   Rao, Xiaoping ^a,c   Gao, Yunling ^a,c   Wang, Jie ^a   Xu, Fuqiang ^a  

^a Wuhan National Laboratory for Optoelectronics   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Alzheimer's disease; A deposition pattern; A PP PS1 transgenic mice; olfactory system

Indexed keywords

AMYLOID BETA PROTEIN; OLFACTORY MARKER PROTEIN; THIOFLAVINE;

AGE; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; OLFACTORY BULB; OLFACTORY CORTEX; OLFACTORY DYSFUNCTION; OLFACTORY EPITHELIUM; OLFACTORY NERVE; OLFACTORY NUCLEUS; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PYRIFORM CORTEX; SENSORY DYSFUNCTION; SENSORY NERVE CELL; SPATIAL MEMORY; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; AΒ DEPOSITION PATTERN; AΒPP/PS1 TRANSGENIC MICE; OLFACTORY SYSTEM;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; EARLY DIAGNOSIS; HUMANS; MICE; MICE, TRANSGENIC; OLFACTION DISORDERS; OLFACTORY BULB; OLFACTORY MUCOSA; PRESENILIN-1;

EID: 84892710151     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122443     Document Type: Article

References (70)

1. Wesson DW,Wilson DA, Nixon RA (2010) Should olfactory dysfunction be used as a biomarker of Alzheimer's disease Expert Rev Neurother 10, 633-635.
2. Williams SS,Williams J, CombrinckM,Christie S, SmithAD, McShane R (2009) Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry 80, 667-670.
3. Berg D (2008) Biomarkers for the early detection of Parkinson's and Alzheimer's disease. Neurodegener Dis 5, 133-136.
4. Arnold SE, Smutzer GS, Trojanowski JQ, Moberg PJ (1998) Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia. Ann N Y Acad Sci 855, 762-775.
5. Talamo BR, Feng WH, Perez-Cruet M, Adelman L, Kosik K, Lee MY, Cork LC, Kauer JS (1991) Pathologic changes in olfactory neurons in Alzheimer's disease. Ann N Y Acad Sci 640, 1-7.
6. Wang J, Eslinger PJ, Doty RL, Zimmerman EK, Grunfeld R, Sun X, Meadowcroft MD, Connor JR, Price JL, Smith MB, Yang QX (2010) Olfactory deficit detected by fMRI in early Alzheimer's disease. Brain Res 1357, 184-194.
7. Sohrabi HR, Bates KA, Weinborn MG, Johnston AN, Bahramian A, Taddei K, Laws SM, Rodrigues M, Morici M, Howard M, Martins G, Mackay-Sim A, Gandy SE, Martins RN (2012) Olfactory discrimination predicts cognitive decline among community-dwelling older adults. Transl Psychiatry 2, e118.
8. Hidalgo J, Chopard G, Galmiche J, Jacquot L, BrandG(2011) Just noticeable difference in olfaction: A discriminative tool between healthy elderly and patients with cognitive disorders associated with dementia. Rhinology 49, 513-518.
9. Schofield PW, Ebrahimi H, Jones AL, Bateman GA, Murray SR (2012) An olfactory 'stress test' may detect preclinical Alzheimer's disease. BMC Neurol 12, 1471-2377.
10. McLaughlin NC, Westervelt HJ (2008) Odor identification deficits in frontotemporal dementia: A preliminary study. Arch Clin Neuropsychol 23, 119-123.
11. Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, Marino S (2012) Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci 323, 16-24.
12. RuanY, ZhengXY, Zhang HL, ZhuW, Zhu J (2012) Olfactory dysfunctions in neurodegenerative disorders. J Neurosci Res 90, 1693-1700.
13. LaFerla FM (2010) Pathways linking Abeta and tau pathologies. Biochem Soc Trans 38, 993-995.
14. Wesson DW, Levy E, Nixon RA, Wilson DA (2010) Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model. J Neurosci 30, 505-514.
15. Wesson DW, Borkowski AH, Landreth GE, Nixon RA, Levy E, Wilson DA (2011) Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's beta-amyloidosis mouse model. J Neurosci 31, 15962-15971.
16. Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, Escoffier G, Marchetti E, KhrestchatiskyM, Rivera S, Roman FS (2012) Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. J Alzheimers Dis 33, 781-796.
17. Tiwari V, Patel AB (2012) Impaired glutamatergic and GABAergic function at early age in AbetaPPswe-PS1dE9 mice: Implications for Alzheimer's disease. J Alzheimers Dis 28, 765-769.
18. Deacon RM, Koros E, Bornemann KD, Rawlins JN (2009) Aged Tg2576 mice are impaired on social memory and open field habituation tests. Behav Brain Res 197, 466-468.
19. Young JW, Sharkey J, FinlaysonK(2009) Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment. Neurobiol Aging 30, 1430-1443.
20. Cassano T, Romano A, Macheda T, Colangeli R, Cimmino CS, Petrella A, LaFerla FM, Cuomo V, Gaetani S (2011) Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res 224, 408-412.
21. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD,Wesson D, Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM,Yang AJ,WilsonDA, St George-Hyslop P,WestawayD, Mathews PM, Levy E, Cuervo AM, NixonRA (2011) Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 134, 258-277.
22. Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, Podlisny MB, Cleary JP, Ashe KH, Rowan MJ, Selkoe DJ (2005) The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochem Soc Trans 33, 1087-1090.
23. Glabe C (2001) Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 17, 137-145.
24. King ME, Kan HM, Baas PW, Erisir A, Glabe CG, Bloom GS (2006) Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J Cell Biol 175, 541-546.
25. Lefterov I, Fitz NF, Cronican A, Lefterov P, Staufenbiel M, Koldamova R (2009) Memory deficits in APP23/Abca1+/- mice correlate with the level of Abeta oligomers. ASN Neuro 1, pii: E00006.
26. Nimmrich V, Ebert U (2009) Is Alzheimer's disease a result of presynaptic failure Synaptic dysfunctions induced by oligomeric beta-amyloid. Rev Neurosci 20, 1-12.
27. Willner P (1985) Antidepressants and serotonergic neurotransmission: An integrative review. Psychopharmacology (Berl) 85, 387-404.
28. Takagi SF (1984) The olfactory nervous system of the old world monkey. Jpn J Physiol 34, 561-573.
29. Beckett TL, Studzinski CM, Keller JN, Paul Murphy M, Niedowicz DM (2013) A ketogenic diet improves motor performance but does not affect beta-amyloid levels in a mouse model of Alzheimer's Disease. Brain Res 1505, 61-67.
30. Gao L, Tian S, Gao H, Xu Y (2013) Hypoxia increases Abeta-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice. J Mol Neurosci, doi: 10.1007/s12031-013-9966-y.
31. Spuch C, Antequera D, Portero A, Orive G, Hernandez RM, Molina JA, Bermejo-Pareja F, Pedraz JL, Carro E (2010) The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials 31, 5608-5618.
32. Wang J, Jiang L, Jiang Y, Ma X, Chowdhury GM, Mason GF (2010) Regional metabolite levels and turnover in the awake rat brain under the influence of nicotine. J Neurochem 113, 1447-1458.
33. Inazu M, Takeda H, Matsumiya T (2003) Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes. J Neurochem 84, 43-52.
34. Chen LM, Xiong YS, Kong FL, Qu M, Wang Q, Chen XQ, Wang JZ, Zhu LQ (2012) Neuroglobin attenuates Alzheimerlike tau hyperphosphorylation by activating Akt signaling. J Neurochem 120, 157-164.
35. Zhou P, Chen Z, Zhao N, Liu D, Guo ZY, Tan L, Hu J, Wang Q, Wang JZ, Zhu LQ (2011) Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities. Rejuvenation Res 14, 669-679.
36. Yang M, Crawley JN (2009) Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci Chapter 8, Unit 8 24.
37. Bayer TA, Wirths O (2011) Intraneuronal Abeta as a trigger for neuron loss: Can this be translated into human pathology Biochem Soc Trans 39, 857-861.
38. de Castro F (2009)Wiring olfaction: The cellular and molecular mechanisms that guide the development of synaptic connections from the nose to the cortex. Front Neurosci 3, 52-.
39. Hasselmo ME, Brandon MP, Yoshida M, Giocomo LM, Heys JG, Fransen E, Newman EL, Zilli EA (2009) A phase code for memory could arise from circuit mechanisms in entorhinal cortex. Neural Netw 22, 1129-1138.
40. Wojtowicz JM (2012) Adult neurogenesis. From circuits to models. Behav Brain Res 227, 490-496.
41. Doty RL (2009) The olfactory system and its disorders. Semin Neurol 29, 74-81.
42. Wisniewski ML, Hwang J, Bahr BA (2011) Submicromolar Abeta42 reduces hippocampal glutamate receptors and presynaptic markers in an aggregation-dependent manner. Biochim Biophys Acta 1812, 1664-1674.
43. Hane F, Drolle E, Gaikwad R, Faught E, Leonenko Z (2011) Amyloid-beta aggregation on model lipid membranes: An atomic force microscopy study. J Alzheimers Dis 26, 485-494.
44. Moores B, Drolle E, Attwood SJ, Simons J, Leonenko Z (2011) Effect of surfaces on amyloid fibril formation. PLoS One 6, e25954.
45. Liu X, Xu K, Yan M, Wang Y, Zheng X (2010) Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress. Neurochem Int 57, 588-599.
46. Lai CS, Preisler J, Baum L, Lee DH, Ng HK, Hugon J, So KF, Chang RC (2009) Low molecular weight Abeta induces collapse of endoplasmic reticulum. Mol Cell Neurosci 41, 32- 43.
47. Ma B, Nussinov R (2011) Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide. J Biol Chem 286, 34244-34253.
48. Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, Teplow DB, Stanley HE (2004) In silico study of amyloid beta-protein folding and oligomerization. Proc Natl Acad Sci U S A 101, 17345-17350.
49. Bayer TA, Wirths O (2011) Intraneuronal A beta as a trigger for neuron loss: Can this be translated into human pathology Biochem Soc Trans 39, 857-861.
50. Dhawan G, Floden AM, Combs CK (2012) Amyloid-beta oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging 33, 2247-2261.
51. Sondag CM, Dhawan G, Combs CK (2009) Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 6, 1.
52. Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, Lee VM, Trojanowski JQ (2010) Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 67, 462-469.
53. Kondo K, Suzukawa K, Sakamoto T,Watanabe K, Kanaya K, Ushio M, Yamaguchi T, Nibu K, Kaga K, Yamasoba T (2010) Age-related changes in cell dynamics of the postnatal mouse olfactory neuroepithelium: Cell proliferation, neuronal differentiation, and cell death. J Comp Neurol 518, 1962-1975.
54. Williams SK, Gilbey T, Barnett SC (2004) Immunohistochemical studies of the cellular changes in the peripheral olfactory system after zinc sulfate nasal irrigation. Neurochem Res 29, 891-901.
55. Lee AC, He J,MaM(2011) Olfactory marker protein is critical for functional maturation of olfactory sensory neurons and development of mother preference. J Neurosci 31, 2974-2982.
56. St John JA, Key B (2005) Olfactory marker protein modulates primary olfactory axon overshooting in the olfactory bulb. J Comp Neurol 488, 61-69.
57. Jankowski R, Schrewelius C, Bonfils P, Saban Y, Gilain L, Prades JM, Strunski V (2001) Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg 127, 447-452.
58. McNamara AM, Magidson PD, Linster C, Wilson DA, Cleland TA(2008) Distinct neural mechanisms mediate olfactory memory formation at different timescales. Learn Mem 15, 117-125.
59. LoscherW, Ebert U (1996) The role of the piriform cortex in kindling. Prog Neurobiol 50, 427-481.
60. Wilson DA (2009) Olfaction as a model system for the neurobiology of mammalian short-term habituation. Neurobiol Learn Mem 92, 199-205.
61. Saiz-Sanchez D, Ubeda-Banon I, De la Rosa-Prieto C, Martinez-Marcos A (2012) Differential expression of interneuron populations and correlation with amyloid-beta deposition in the olfactory cortex of an AbetaPP/PS1 transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 31, 113-129.
62. Wesson DW, Morales-Corraliza. J, Mazzella MJ, Wilson DA, Mathews PM (2013) Chronic anti-murine Abeta immunization preserves odor guided behaviors in an Alzheimer's beta-amyloidosis model. Behav Brain Res 237, 96-102.
63. Cavada C, Company T, Tejedor J, Cruz-Rizzolo RJ, Reinoso- Suarez F (2000) The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cereb Cortex 10, 220- 242.
64. Prestia A, Drago V, Rasser PE, Bonetti M, Thompson PM, Frisoni GB (2010) Cortical changes in incipient Alzheimer's disease. J Alzheimers Dis 22, 1339-1349.
65. Squire LR (2009) Memory and brain systems: 1969-2009. J Neurosci 29, 12711-12716.
66. van Groen T (2001) Entorhinal cortex of the mouse: Cytoarchitectonical organization. Hippocampus 11, 397-407.
67. Polunina AG, Briun EA (2011) [Orbitofrontal cortex in the genesis of in drug addiction]. Zh Nevrol Psikhiatr Im S S Korsakova 111, 102-109.
68. Sharma S, Rakoczy S, Brown-Borg H (2010) Assessment of spatial memory in mice. Life Sci 87, 521-536.
69. Cappaert NL,Wadman WJ,WitterMP(2007) Spatiotemporal analyses of interactions between entorhinal and CA1 projections to the subiculum in rat brain slices. Hippocampus 17, 909-921.
70. Stranahan AM,Mattson MP (2010) Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plas 2010, 108190.